Major decision: Big 4 TAS vs Pharma FMP [Europe]

Currently I am finishing my Master's (Accounting & Finance) in EU/Germany. Soon I'll have to start looking for a job after graduation and I see two possible paths where I'm not sure which one is more promising. I searched on this side for more info but I didnt find info that directly fit my question (but I did find some info on audit vs GE FMP in the US at least)

Option 1:
Big 4 TAS
[I interned in audit and later in TAS at Big 4 companies and as long as I dont have to deal with fk controls I'm okay with the work (I do like excel. Also I know that it might not be the case in the US but in Germany TAS does hire directly after uni)]
-> in 2-5 years: Switch to Industry, probably FP&A preferable in pharma/biotech (or chemicals, fmcg, automotive). I would love M&A/CDev but thats probably more of long shot.

Pro: Big 4 brand, Experience in different industries, more variety of tasks (maybe?), More diverse opportunies later on*
Con: TAS might be a bit of a niche, Money and work hours, not sure how easy it is to find a good exit opportunity, might not have the opportunity to work in the industry I'm interested in (mostly pharma)

Option 2:
Finance graduate/trainee programm (FMP) at a major pharma company (Bayer, Novartis, Roche etc)
[I interned in Corporate FP&A for subsidiaries and liked the tasks well enough, also I'm excited about the industry and dont mind the money (best paying industry on avg for finance behind automotive).]
-> 2 or 3 years with several rotations then most likely some FP&A job at the company (probably similar to the US, they usually dont let go of people after graduate programms bc they are pretty expensive to run for them)
-> No obvious reason to switch jobs but I assume I'd be able to switch between major pharma companies

Pro: Already inside goal industry, Pay, Work hours, reasonable brandname, rotation abroad during the programm
Con: Worse locations, probably less variety in the first years after the graduate programm, probably even harder to get into corp. M&A/CD (But they do have some people working in corp M&A after the graduate program so it is not impossible), probably harder to go into an other industry

That being said, some more thoughts:
- Money is not really an issue when starting out. Since we dont have tuition fees I was able to even save money as a student from part time jobs so I really dont care if I earn 45-50T€ (big 4) or 55-65T€ (pharma) during my first years. I'm interessted in my long term earning potential thought
- Working hours in the next couple of years I dont really care about to much, I'm not in a relationship and both options dont really fit for that (graduate programm would involve less hours but several moves to different cities including one placament abroad)
- While I am excited about pharma/biotech it probably would not be the end of the world if I ended up working in a different manufactoring sector (chemical, automotive etc)
- I dont really care about PE/IB positions which is I think a motivation for some people to join TAS
- We have something similar to the CPA but it usually takes longer (most people pass it arround after 4-5 years at the Big 4 and thats usually when you get promoted to Manager in audit. In TAS the people usually take the exams as well but often even a bit later BC it is not needed to get the manager level. Some people (less in FDD, more in Val) go for the CFA instead) and is not necessary for jobs outside the big 4
- Big 4 would allow me to build a bigger and more diverse network whereas if i start at the pharma company I will meet few people from other companies and especially at the european companies there is not that much job switching
-* TAS would probably allow me to go into some fields that I even cant think of right now, in less well known areas (what might that be?)

I have discussed this topic with several people from both industries and with some friends but still wasnt really able to make a decision. I was hoping that maybe someone from this forum might have some valuable insights.
Thanks!

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (145) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
kanon's picture
kanon
98.9
9
Jamoldo's picture
Jamoldo
98.8
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”